COVID-19 in Lymphangioleiomyomatosis An International Study of Outcomes and Impact of Mechanistic Target of Rapamycin Inhibition - Archive ouverte HAL Access content directly
Journal Articles Chest Year : 2022

COVID-19 in Lymphangioleiomyomatosis An International Study of Outcomes and Impact of Mechanistic Target of Rapamycin Inhibition

(1) , (2) , (2) , (3) , (4) , (1) , (5, 6) , (7) , (8) , (9) , (10) , (11)
1
2
3
4
5
6
7
8
9
10
11

Dates and versions

hal-03837879 , version 1 (03-11-2022)

Identifiers

Cite

Bruno Guedes Baldi, Elzbieta Radzikowska, Vincent Cottin, Daniel Dilling, Ali Ataya, et al.. COVID-19 in Lymphangioleiomyomatosis An International Study of Outcomes and Impact of Mechanistic Target of Rapamycin Inhibition. Chest, 2022, 161 (6), pp.1589-1593. ⟨10.1016/j.chest.2021.12.640⟩. ⟨hal-03837879⟩
0 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More